IVDA vs LBGJ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IVDA exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. The company is experiencing a collapse in top-line growth with revenue declining by 64.10% YoY, coupled with an unsustainable operating margin of -262.71%. Despite a deceptively high current ratio, the massive erosion in shareholder value (-99.6% over 5 years) and a total lack of analyst coverage suggest a company in a death spiral. The technical trend is completely bearish, and the valuation metrics are typical of a value trap.
LBGJ exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a catastrophic price collapse from a 52-week high of $200.00 to $1.09. While the Price-to-Book (0.03) and Price-to-Sales (0.19) ratios appear superficially attractive, they are classic indicators of a value trap given the negative profit margins and declining revenue growth. The company's technical trend is completely bearish, with a 5-year price decline of 99.7%, suggesting a total loss of investor confidence.
Compare Another Pair
Related Comparisons
IVDA vs LBGJ: Head-to-Head Comparison
This page compares Iveda Solutions, Inc. (IVDA) and Li Bang International Corporation Inc. (LBGJ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.